Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02ZPM
|
|||
| Former ID |
DIB012993
|
|||
| Drug Name |
Anpirtoline
|
|||
| Synonyms |
D-16949
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Pain [ICD-11: MG30-MG3Z] | Terminated | [1] | |
| Company |
ASTA Medica AG
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H13ClN2S
|
|||
| Canonical SMILES |
C1CNCCC1SC2=NC(=CC=C2)Cl
|
|||
| InChI |
1S/C10H13ClN2S/c11-9-2-1-3-10(13-9)14-8-4-6-12-7-5-8/h1-3,8,12H,4-7H2
|
|||
| InChIKey |
GGALEXMXDMUMDM-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 98330-05-3
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:92968
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | 5-HT 1A receptor (HTR1A) | Target Info | Modulator | [1] |
| 5-HT 1B receptor (HTR1B) | Target Info | Modulator | [1] | |
| KEGG Pathway | cAMP signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| Serotonergic synapse | ||||
| Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
| 5HT1 type receptor mediated signaling pathway | ||||
| Reactome | Serotonin receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | Serotonin HTR1 Group and FOS Pathway | |||
| Monoamine GPCRs | ||||
| GPCRs, Class A Rhodopsin-like | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| SIDS Susceptibility Pathways | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Effects of anpirtoline on regional serotonin synthesis in the rat brain: an autoradiographic study. Nucl Med Biol. 2006 Apr;33(3):325-32. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.